Maravai Lifesciences Holdings (MRVI) Finished Goods (2020 - 2026)

Maravai Lifesciences Holdings' Finished Goods history runs 7 years deep, the most recent figure standing at $18.6 million for Q1 2026.

• On a quarterly basis, Finished Goods fell 17.74% year-over-year to $18.6 million in Q1 2026; TTM through Mar 2026 was $18.6 million, a 17.74% decrease from a year earlier, with the FY2025 full-year figure at $18.6 million, down 19.46% from the prior year.
• Finished Goods was little changed at $18.6 million in Q1 2026 per MRVI's latest filing, from $18.6 million in the prior quarter.
• Across five years, Finished Goods topped out at $23.1 million in Q4 2024 and bottomed at $7.3 million in Q2 2023.
• The 5-year median for Finished Goods is $18.6 million (2026), against an average of $16.2 million.
• Across the five-year window, Finished Goods dropped 26.16% in 2022 and surged 185.77% in 2024, its largest moves.
• Year by year, Finished Goods stood at $7.7 million in 2022, then jumped by 151.15% to $19.4 million in 2023, then rose by 18.98% to $23.1 million in 2024, then decreased by 19.46% to $18.6 million in 2025, then climbed by 0.33% to $18.6 million in 2026.
• Per Business Quant, the three latest MRVI Finished Goods figures stand at $18.6 million (Q1 2026), $18.6 million (Q4 2025), and $19.6 million (Q3 2025).